Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05545176

The Validation and Development of Termination-of-Resuscitation (TOR) Rules in OHCA Patients in Asia Countries

The Validation and Development of Termination-of-Resuscitation (TOR) Rules in Patients Following Out-of-Hospital Cardiac Arrest (OHCA) in Asia Countries

Status
Recruiting
Phase
Study type
Observational
Enrollment
140,000 (estimated)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Objectives/Hypotheses 1. Prehospital termination-of-resuscitation (TOR) rules were developed in North American and European sites. Whether they remained valid in different geographic, ethnic, and cultural background areas is still under debate. 2. Differences in characteristics of out-of-hospital cardiac arrests (OHCAs) and configurations of emergency medical service (EMS) between the Western and Asian countries, including relatively lower rate of presenting shockable rhythm (i.e. ventricular fibrillation / ventricular tachycardia; VF/VT), lower rates of bystander CPR, less advanced life support (ALS) implementation, and less public access defibrillators, might create potential threats to the prediction accuracy of TOR rules. 3. We aim to conduct a study to validate the performance of ever published TOR rules in Asian OHCA population, including non-traumatic, traumatic, and pediatric OHCA patients. Furthermore, assess the possible variables that may impact the performance of TOR rules. 4. We also aim to develop new TOR rules based on PAROS registry for Asia population, focusing on non-traumatic, traumatic, and pediatric OHCA patients, respectively.

Conditions

Interventions

TypeNameDescription
OTHERtermination of resuscitation rulesUse retrospective data to analyze the accuracy termination of resuscitation rules and further develope a termination of resuscitation rule.

Timeline

Start date
2007-01-01
Primary completion
2032-06-01
Completion
2032-12-31
First posted
2022-09-19
Last updated
2026-02-25

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05545176. Inclusion in this directory is not an endorsement.